Growth Metrics

Immunocore Holdings (IMCR) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $609.3 million.

  • Immunocore Holdings' Total Non-Current Liabilities fell 1342.32% to $609.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $609.3 million, marking a year-over-year decrease of 1342.32%. This contributed to the annual value of $648.8 million for FY2024, which is 18558.41% up from last year.
  • As of Q3 2025, Immunocore Holdings' Total Non-Current Liabilities stood at $609.3 million, which was down 1342.32% from $609.9 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Total Non-Current Liabilities high stood at $703.8 million for Q3 2024, and its period low was $185.6 million during Q4 2022.
  • Moreover, its 4-year median value for Total Non-Current Liabilities was $609.9 million (2025), whereas its average is $540.7 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 18558.41% in 2024, then tumbled by 1342.32% in 2025.
  • Immunocore Holdings' Total Non-Current Liabilities (Quarter) stood at $185.6 million in 2022, then grew by 22.37% to $227.2 million in 2023, then soared by 185.58% to $648.8 million in 2024, then fell by 6.08% to $609.3 million in 2025.
  • Its Total Non-Current Liabilities stands at $609.3 million for Q3 2025, versus $609.9 million for Q2 2025 and $587.1 million for Q1 2025.